Key Takeaways Infant formula makers Abbott and Reckitt saw their stocks decline Friday after a judge ruled plaintiffs could ...

Health and Human Services Secretary Robert F. Kennedy Jr. is planning to meet Tuesday with executives of companies that make ...

Abbott Laboratories and Reckitt Benckiser Group Plc shares fell as a judge ordered a new trial after rejecting a verdict that ...

Reckitt Benckiser’s Mead Johnson unit and Abbott Laboratories have been ordered to face a new trial in the US over ...

Reckitt said on Friday a circuit court in the United States had ruled that a new trial could be sought by plaintiffs in a ...

Back in October, a jury found North Chicago-based Abbott and Reckitt’s formula subsidiary Mead Johnson not responsible for a ...

Abbott Laboratories' medical device business is executing well, with double-digit growth in structural heart and diabetes.

Shares of Abbott Laboratories and Reckitt Benckiser fell Friday after a judge ruled a new trial could be heard involving a case on their infant formula products that had already seen a ruling in their ...

Missouri 22nd Judicial Circuit Court Judge Michael Noble granted the plaintiff's motion for a new trial on Thursday, citing ...

The ruling overturned a previous verdict related to an infant formula case and has implications for both Abbott and Reckitt, ...

The decision to allow a new trial could have  implications for both the companies and families with babies born prematurely.

Abbott was down 2.7% at 1:54 p.m. in New York after paring morning losses, while Reckitt’s shares fell as much as 5.6% in London before closing down 1.7%. Both early declines were the biggest in ...